Diagnostic value of flow cytometry immunophenotype for Multiple Myeloma
Wei Lü
Abstract
Wei Lü
Abstract
Objective To explore the effect of immunophenotype for diagnoses of patients with multiple myeloma(MM).Methods CD45/side scatter(ssc) gating four-color immunofluorescence multiparameter flow cytometry(MP-FCM) was used to test immunophenotype of 35 MM patients and 10 patients with secondary monoclonal gammopathy.Results Myeloma cells displayed both CD138 and CD38 strong positive expression,mean fluorescence intensity(MFI) were 695.2±120.6 and 956.23±436.2.CD56 was strong positive in 91.43%(32/35)cases,the MFI was 779.9±241.0.While CD19 was negative in 33 cases and CD45 was all negative/low positive.The results of patients with secondary monoclonal gammopathy show that CD38 and CD138 were strong positive,the MFI were 621.3±82.8 and 549.6±132.7.CD56 was negative in control group patients,the MFI only was 24.61±13.1.while CD19 was positive in 8 patients and CD45 was all positive.Expressed fluorescence Strength of CD44,myeloma cells was significant strong than secondary monoclonal gammopathy cells.Conclusion MP-FCM is an important diagnostic method for MM and testing CD38,CD138,CD19,CD56,CD45 and CD44 can help distinguish myeloma cells from plasma cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effect of immunophenotype for diagnoses of patients with multiple myeloma(MM).Methods CD45/side scatter(ssc) gating four-color immunofluorescence multiparameter flow cytometry(MP-FCM) was used to test immunophenotype of 35 MM patients and 10 patients with secondary monoclonal gammopathy.Results Myeloma cells displayed both CD138 and CD38 strong positive expression,mean fluorescence intensity(MFI) were 695.2±120.6 and 956.23±436.2.CD56 was strong positive in 91.43%(32/35)cases,the MFI was 779.9±241.0.While CD19 was negative in 33 cases and CD45 was all negative/low positive.The results of patients with secondary monoclonal gammopathy show that CD38 and CD138 were strong positive,the MFI were 621.3±82.8 and 549.6±132.7.CD56 was negative in control group patients,the MFI only was 24.61±13.1.while CD19 was positive in 8 patients and CD45 was all positive.Expressed fluorescence Strength of CD44,myeloma cells was significant strong than secondary monoclonal gammopathy cells.Conclusion MP-FCM is an important diagnostic method for MM and testing CD38,CD138,CD19,CD56,CD45 and CD44 can help distinguish myeloma cells from plasma cells.
Key concepts: Immunophenotyping, Multiple myeloma, Flow cytometry, Medicine, CD38, Monoclonal gammopathy of undetermined significance, Immunofluorescence, CD44